KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Nektar Therapeutics (NKTR) Long-Term Debt Repayments: 2010-2017

Historic Long-Term Debt Repayments for Nektar Therapeutics (NKTR) over the last 8 years, with Dec 2017 value amounting to $3.0 million.

  • Nektar Therapeutics' Long-Term Debt Repayments rose 422.32% to $3.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $5.1 million, marking a year-over-year decrease of 13.69%. This contributed to the annual value of $5.1 million for FY2017, which is 13.69% down from last year.
  • According to the latest figures from Q4 2017, Nektar Therapeutics' Long-Term Debt Repayments is $3.0 million, which was up 276.20% from $790,000 recorded in Q3 2017.
  • In the past 5 years, Nektar Therapeutics' Long-Term Debt Repayments ranged from a high of $3.0 million in Q4 2017 and a low of $569,000 during Q4 2016.
  • Its 3-year average for Long-Term Debt Repayments is $1.4 million, with a median of $1.4 million in 2015.
  • Examining YoY changes over the last 5 years, Nektar Therapeutics' Long-Term Debt Repayments showed a top increase of 422.32% in 2017 and a maximum decrease of 64.42% in 2017.
  • Over the past 5 years, Nektar Therapeutics' Long-Term Debt Repayments (Quarterly) stood at $791,000 in 2013, then increased by 21.11% to $958,000 in 2014, then soared by 44.99% to $1.4 million in 2015, then tumbled by 59.04% to $569,000 in 2016, then surged by 422.32% to $3.0 million in 2017.
  • Its Long-Term Debt Repayments was $3.0 million in Q4 2017, compared to $790,000 in Q3 2017 and $756,000 in Q2 2017.